For help on how to get the results you want, see our search tips.
10 results
Categories
Human Remove Human filter
-
List item
Summary of opinion: Binocrit
epoetin alfa, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Epoetin Alfa Hexal
epoetin alfa, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Abseamed
epoetin alfa, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Hemlibra
emicizumab, opinion date: 31/01/2019, Positive, Last updated: 01/02/2019 -
List item
Summary of opinion: Soliris
eculizumab, opinion date: 25/07/2019, Positive, Last updated: 26/07/2019 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 17/10/2019, Positive, Last updated: 18/10/2019 -
List item
Summary of opinion: Grasustek
pegfilgrastim, opinion date: 26/04/2019, Positive, Last updated: 26/04/2019 -
List item
Summary of opinion: Remsima
infliximab, opinion date: 19/09/2019, Positive, Last updated: 20/09/2019 -
List item
Referral: Lartruvo
olaratumab, associated names: Lartruvo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 31/01/2019, EC decision date: 19/07/2019, Last updated: 22/08/2019 -
List item
Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)
daclatasvir / dasabuvir / sofosbuvir / ledipasvir / simeprevir / ombitasvir/paritaprevir / ritonavir, associated names: Sovaldi, Olysio, Viekirax, Harvoni, Exviera, Daklinza, Article 20 procedures
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 23/02/2017, Last updated: 09/03/2017